Psychopharmacology News and Research

RSS

Psychopharmacology is the study of drug-induced changes in mood, sensation, thinking, and behavior.

Mephedrone may cause memory loss

The party drug mephedrone can cause lasting damage to the brain, according to new research led by the University of Sydney.

19 Sep 2012

Antipsychotic-induced obsessive compulsive symptoms assessed

Results from a Korean study show that the symptom structure of second-generation-antipsychotic-induced obsessive compulsive symptoms is similar to that seen in patients with “pure” obsessive compulsive disorder.

7 Sep 2012

MAOA gene appears to make women happy

A new study has found a gene that appears to make women happy, but it doesn't work for men. The finding may help explain why women are often happier than men, the research team said.

29 Aug 2012

Combination of two existing pharmaceutical drugs shows promise against cocaine addiction

A fine-tuned combination of two existing pharmaceutical drugs has shown promise as a potential new therapy for people addicted to cocaine—a therapy that would reduce their craving for the drug and blunt their symptoms of withdrawal.

9 Aug 2012

Oxidative stress linked to NSS severity in schizophrenia

The severity of neurologic soft signs negatively correlates with antioxidant superoxide dismutase activity in patients with schizophrenia, research shows.

14 Jun 2012

Novel guidelines manage youth maladaptive aggression

Recommendations for the engagement, assessment, treatment, and management of maladaptive aggression in youth have been developed by US experts to improve treatment planning and selection.

6 Jun 2012

Positive results from Alkermes’ ALKS 5461 phase 1/2 study on MDD

Alkermes plc today presented positive results from the phase 1/2 study of ALKS 5461, a novel drug compound for major depressive disorder (MDD) in patients who have an inadequate response to standard therapies for clinical depression, in an oral session at the 52nd Annual New Clinical Drug Evaluation Unit (NCDEU) Meeting in Phoenix.

30 May 2012

New BAP guidelines target treatment of substance abuse, addiction

The British Association for Psychopharmacology (BAP) has released fresh guidelines on the best methods to treat substance abuse and addiction in the Journal of Psychopharmacology, published by SAGE.

23 May 2012

Kudzu root components may treat alcoholism and curb binge drinking

An extract of the Chinese herb kudzu dramatically reduces drinking and may be useful in the treatment of alcoholism and curbing binge drinking, according to a new study by McLean Hospital and Harvard Medical School researchers.

18 May 2012

Ritalin use in ADHD rises four-fold over a decade

According to latest figures prescriptions for Ritalin for attention deficit hyperactivity disorder (ADHD) have quadrupled in a decade. This has raised concerns that it is being given to children at the expense of alternative treatments and without appreciation of long-term effects.

8 May 2012

Varenicline reduces alcohol intake among heavy-drinking smokers

The smoking cessation drug varenicline significantly reduced alcohol consumption in a group of heavy-drinking smokers, in a study carried out by researchers at the Ernest Gallo Clinic and Research Center at the University of California, San Francisco.

4 May 2012

Elsevier, AAGP partner to publish American Journal of Geriatric Psychiatry

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces that it has entered into an agreement with the American Association for Geriatric Psychiatry (AAGP) to publish The American Journal of Geriatric Psychiatry (AJGP) beginning in January 2013.

3 May 2012

LSD for alcohol addiction: Study

Hallucinogenic drug LSD (lysergic acid diethylamide) could help alcoholics give up drinking, according to an analysis of studies performed in the 1960s. A study, presented in the Journal of Psychopharmacology, looked at data from six trials and more than 500 patients. It said there was a “significant beneficial effect” on alcohol abuse, which lasted several months after the drug was taken.

12 Mar 2012

Single dose of LSD shows promise against alcoholism

Forty years ago, LSD was used in the treatment of alcoholics - with good results. Perhaps it's time to look at it again? In the 1950s, '60s and '70s, researchers in many places in the world experimented with LSD in the treatment of various disorders, including alcoholism. Not all experiments were scientifically tenable by today's standards, but some were.

9 Mar 2012

Heart rate lowering drug may reduce “implicit” racial prejudices: Study

It was found that volunteers given the beta-blocker, used to treat chest pains and lower heart rates, scored lower on a standard psychological test of “implicit” racist attitudes. They appeared to be less racially prejudiced at a subconscious level than another group treated with a “dummy” placebo pill.

8 Mar 2012

Rosemary aroma may improve cognitive performance

Hailed since ancient times for its medicinal properties, we still have a lot to learn about the effects of rosemary. Now researchers writing in Therapeutic Advances in Psychopharmacology, published by SAGE, have shown for the first time that blood levels of a rosemary oil component correlate with improved cognitive performance.

26 Feb 2012

Positive emotional experience induces people to visit social networking sites

People visit social networking sites such as Facebook for many reasons, including the positive emotional experience that people enjoy and want to repeat, according to an article in Cyberpsychology, Behavior, and Social Networking, a peer-reviewed journal published by Mary Ann Liebert, Inc..

8 Feb 2012

Scientists reveal how psychostimulant drugs work to control hyperactivity

It has long been known that psychostimulant drugs have the paradoxical effect of reducing hyperactivity. [Psychostimulant drugs include methylphenidate - known by the trade names Ritalin, Concerta, and Methylin - and methamphetamine]. Since the mid-1950s, millions of children and adults have been prescribed stimulant medications to control attention deficit hyperactivity disorder.

8 Feb 2012

New editorial offers clarity on confusing drug and alcohol addiction terminology

A new editorial released this week offers clarity and structure on confusing drug and alcohol addiction terminology for prescribers, users and regulators. "Through a glass darkly: can we improve clarity about mechanism and aims of medications in drug and alcohol treatments?" is published in the Journal of Psychopharmacology, the official journal of the British Association for Psychopharmacology, published by SAGE.

4 Feb 2012

Roundtable discussion about caffeine and physical performance

Caffeine is regarded by some as being a potent stimulant, but the debate continues as to whether it enhances exercise performance. A range of expert opinions capture the scope of this ongoing debate in an informative roundtable discussion published in Journal of Caffeine Research, a quarterly peer-reviewed journal from Mary Ann Liebert, Inc.

15 Dec 2011